Found: 88
Select item for more details and to access through your institution.
Optimization and validation of a virus‐like particle pseudotyped virus neutralization assay for SARS‐CoV‐2.
- Published in:
- MedComm, 2024, v. 5, n. 6, p. 1, doi. 10.1002/mco2.615
- By:
- Publication type:
- Article
SARS-CoV-2 Neutralization Assays Used in Clinical Trials: A Narrative Review.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 554, doi. 10.3390/vaccines12050554
- By:
- Publication type:
- Article
COVID-19 Serum Drives Spike-Mediated SARS-CoV-2 Variation.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 5, p. 763, doi. 10.3390/v16050763
- By:
- Publication type:
- Article
Multi-epitope vaccine design for hepatitis E virus based on protein ORF2 and ORF3.
- Published in:
- Frontiers in Microbiology, 2024, p. 1, doi. 10.3389/fmicb.2024.1372069
- By:
- Publication type:
- Article
Development of a SARS‐CoV‐2 neutralization assay based on a pseudotyped virus using a HIV system.
- Published in:
- MedComm, 2024, v. 5, n. 4, p. 1, doi. 10.1002/mco2.517
- By:
- Publication type:
- Article
Establishment of the First National Standard for Neutralizing Antibodies against SARS-CoV-2 XBB Variants.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 4, p. 554, doi. 10.3390/v16040554
- By:
- Publication type:
- Article
A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus.
- Published in:
- eLife, 2024, p. 1, doi. 10.7554/eLife.91181
- By:
- Publication type:
- Article
The establishment of a multiplex fluorescent polymerase chain reaction coupled with capillary electrophoresis analysis technology enables the simultaneous detection of 16 genotypes of human papillomavirus.
- Published in:
- Journal of Clinical Laboratory Analysis, 2024, v. 38, n. 1/2, p. 1, doi. 10.1002/jcla.24996
- By:
- Publication type:
- Article
Rational prediction of immunogenicity clustering through cross‐reactivity analysis of thirteen SARS‐CoV‐2 variants.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 1, p. 1, doi. 10.1002/jmv.29314
- By:
- Publication type:
- Article
Immune escape of BA.2.86 is comparable to XBB subvariants from the plasma of BA.5‐ and BA.5‐XBB‐convalescent subpopulations.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 1, p. 1, doi. 10.1002/jmv.29417
- By:
- Publication type:
- Article
Intranasal mask for protecting the respiratory tract against viral aerosols.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-44134-w
- By:
- Publication type:
- Article
Intranasal mask for protecting the respiratory tract against viral aerosols.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-44134-w
- By:
- Publication type:
- Article
Author Correction: A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Smoke and Spike: Benzo[a]pyrene Enhances SARS‐CoV‐2 Infection by Boosting NR4A2‐Induced ACE2 and TMPRSS2 Expression (Adv. Sci. 26/2023).
- Published in:
- Advanced Science, 2023, v. 10, n. 26, p. 1, doi. 10.1002/advs.202370178
- By:
- Publication type:
- Article
Smoke and Spike: Benzo[a]pyrene Enhances SARS‐CoV‐2 Infection by Boosting NR4A2‐Induced ACE2 and TMPRSS2 Expression.
- Published in:
- Advanced Science, 2023, v. 10, n. 26, p. 1, doi. 10.1002/advs.202300834
- By:
- Publication type:
- Article
Characterization of a human–mouse chimeric monoclonal antibody targeting rabies virus glycoprotein.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 7, p. 1, doi. 10.1002/jmv.28954
- By:
- Publication type:
- Article
Development of a Bioluminescent Imaging Mouse Model for SARS-CoV-2 Infection Based on a Pseudovirus System.
- Published in:
- Vaccines, 2023, v. 11, n. 7, p. 1133, doi. 10.3390/vaccines11071133
- By:
- Publication type:
- Article
Comparing T- and B-cell responses to COVID-19 vaccines across varied immune backgrounds.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, p. 1, doi. 10.1038/s41392-023-01422-7
- By:
- Publication type:
- Article
Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01432-5
- By:
- Publication type:
- Article
High-throughput screening of spike variants uncovers the key residues that alter the affinity and antigenicity of SARS-CoV-2.
- Published in:
- Cell Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41421-023-00534-2
- By:
- Publication type:
- Article
Screening and identification of HTNVpv entry inhibitors with high-throughput pseudovirus-based chemiluminescence.
- Published in:
- Virologica Sinica (16740769), 2023, v. 38, n. 2, p. 531, doi. 10.1016/j.virs.2022.04.015
- By:
- Publication type:
- Article
Construction and immunogenicity of an mRNA vaccine against chikungunya virus.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1129118
- By:
- Publication type:
- Article
Heterologous prime-boost immunisation with mRNAand AdC68-based 2019-nCoV variant vaccines induces broad-spectrum immune responses in mice.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1142394
- By:
- Publication type:
- Article
Long‐term variations and potency of neutralizing antibodies against Omicron subvariants after CoronaVac‐inactivated booster: A 7‐month follow‐up study.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 1, p. 1, doi. 10.1002/jmv.28279
- By:
- Publication type:
- Article
Efficacy of an accelerated vaccination schedule against hepatitis E virus infection in pregnant rabbits.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 1, p. 1, doi. 10.1002/jmv.28193
- By:
- Publication type:
- Article
Analysis of cross neutralizing activity of antibodies from sera of severe fever with thrombocytopenia syndrome patients to deal with different genotype strains.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.1020545
- By:
- Publication type:
- Article
Assessment of the immunogenicity and protection of a Nipah virus soluble G vaccine candidate in mice and pigs.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.1031523
- By:
- Publication type:
- Article
A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD.
- Published in:
- Cell Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41421-022-00443-w
- By:
- Publication type:
- Article
Screening and identification of HTNVpv entry inhibitors with high-throughput pseudovirus-based chemiluminescence.
- Published in:
- Virologica Sinica (16740769), 2022, v. 37, n. 4, p. 531, doi. 10.1016/j.virs.2022.04.015
- By:
- Publication type:
- Article
Long-Term Infection and Pathogenesis in a Novel Mouse Model of Human Respiratory Syncytial Virus.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 8, p. 1740, doi. 10.3390/v14081740
- By:
- Publication type:
- Article
Cross-reactivity of eight SARS-CoV-2 variants rationally predicts immunogenicity clustering in sarbecoviruses.
- Published in:
- Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-01123-7
- By:
- Publication type:
- Article
Novel cleavage sites identified in SARS-CoV-2 spike protein reveal mechanism for cathepsin L-facilitated viral infection and treatment strategies.
- Published in:
- Cell Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41421-022-00419-w
- By:
- Publication type:
- Article
Antigenicity comparison of SARS‐CoV‐2 Omicron sublineages with other variants contained multiple mutations in RBD.
- Published in:
- MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.130
- By:
- Publication type:
- Article
Characterization of Chronic Hepatitis E Virus Infection in Immunocompetent Rabbits.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 6, p. N.PAG, doi. 10.3390/v14061252
- By:
- Publication type:
- Article
Immunogenicity and Safety of a 3-Dose Regimen of a SARS-CoV-2 Inactivated Vaccine in Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
- Published in:
- Journal of Infectious Diseases, 2022, v. 225, n. 10, p. 1701, doi. 10.1093/infdis/jiab627
- By:
- Publication type:
- Article
Cover Image, Volume 94, Number 5, May 2022.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 5, p. i, doi. 10.1002/jmv.27865
- By:
- Publication type:
- Article
Cover Image, Volume 94, Number 5, May 2022.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 5, p. i, doi. 10.1002/jmv.27865
- By:
- Publication type:
- Article
Aggregation of high‐frequency RBD mutations of SARS‐CoV‐2 with three VOCs did not cause significant antigenic drift.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 5, p. 2108, doi. 10.1002/jmv.27596
- By:
- Publication type:
- Article
Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates.
- Published in:
- Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-00926-y
- By:
- Publication type:
- Article
A non-ACE2-blocking neutralizing antibody against Omicron-included SARS-CoV-2 variants.
- Published in:
- 2022
- By:
- Publication type:
- Letter
High-Throughput Screening and Identification of Human Adenovirus Type 5 Inhibitors.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2021, v. 11, p. 1, doi. 10.3389/fcimb.2021.767578
- By:
- Publication type:
- Article
Neolithic bone meal with acorn: Analyses on crusts in pottery bowls from 7000 BP Hemudu, China.
- Published in:
- International Journal of Osteoarchaeology, 2021, v. 31, n. 6, p. 1138, doi. 10.1002/oa.3026
- By:
- Publication type:
- Article
Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02728-4
- By:
- Publication type:
- Article
Distinct BCR repertoires elicited by SARS-CoV-2 RBD and S vaccinations in mice.
- Published in:
- 2021
- By:
- Publication type:
- Letter
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25331-x
- By:
- Publication type:
- Article
Three epitope-distinct human antibodies from RenMab mice neutralize SARS-CoV-2 and cooperatively minimize the escape of mutants.
- Published in:
- Cell Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41421-021-00292-z
- By:
- Publication type:
- Article
Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24514-w
- By:
- Publication type:
- Article
The molecular basis for SARS-CoV-2 binding to dog ACE2.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24326-y
- By:
- Publication type:
- Article
Methods to Identify Immunogenic Peptides in SARS‐CoV‐2 Spike and Protective Monoclonal Antibodies in COVID‐19 Patients.
- Published in:
- Small Methods, 2021, v. 5, n. 7, p. 1, doi. 10.1002/smtd.202100058
- By:
- Publication type:
- Article
The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.687869
- By:
- Publication type:
- Article